Pacific Bio (NASDAQ: PACB) reported Q1 EPS of ($0.20), versus ($0.20) reported last year. Revenue for the quarter came in at $16.43 million, versus $19.36 million reported last year.

For earnings history and earnings-related data on Pacific Bio (PACB) click here.